Lost in translation: animal models and clinical trials in cancer treatment.

PubWeight™: 1.63‹?› | Rank: Top 4%

🔗 View Article (PMC 3902221)

Published in Am J Transl Res on January 15, 2014

Authors

Isabella Wy Mak1, Nathan Evaniew1, Michelle Ghert1

Author Affiliations

1: Department of Surgery, McMaster University Hamilton, Ontario, Canada ; Juravinski Cancer Centre, Hamilton Health Sciences Hamilton, Ontario, Canada.

Articles citing this

Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature (2016) 1.97

Organs-on-chips at the frontiers of drug discovery. Nat Rev Drug Discov (2015) 1.95

Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies. ACS Biomater Sci Eng (2015) 0.95

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell (2016) 0.95

Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Des Devel Ther (2014) 0.92

Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials. Brain Inj (2015) 0.91

The significance of meaning: why do over 90% of behavioral neuroscience results fail to translate to humans, and what can we do to fix it? ILAR J (2014) 0.88

The flaws and human harms of animal experimentation. Camb Q Healthc Ethics (2015) 0.86

A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoids. Elife (2016) 0.86

In silico methods for drug repurposing and pharmacology. Wiley Interdiscip Rev Syst Biol Med (2016) 0.85

Microenvironment of tumor-draining lymph nodes: opportunities for liposome-based targeted therapy. Int J Mol Sci (2014) 0.84

Preclinical models of pancreatic ductal adenocarcinoma. J Pathol (2015) 0.83

Translational horizons in the tumor microenvironment: harnessing breakthroughs and targeting cures. Med Res Rev (2015) 0.83

Introducing Therioepistemology: the study of how knowledge is gained from animal research. Lab Anim (NY) (2017) 0.82

Common cancer in a wild animal: the California sea lion (Zalophus californianus) as an emerging model for carcinogenesis. Philos Trans R Soc Lond B Biol Sci (2015) 0.82

Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer. Nat Rev Clin Oncol (2016) 0.80

BET protein inhibitor JQ1 inhibits growth and modulates WNT signaling in mesenchymal stem cells. Stem Cell Res Ther (2016) 0.79

Year in review 2013: Critical Care--respirology. Crit Care (2014) 0.79

Synergistic COX2 Induction by IFNγ and TNFα Self-Limits Type-1 Immunity in the Human Tumor Microenvironment. Cancer Immunol Res (2016) 0.78

Transgenerational inheritance of metabolic disease. Semin Cell Dev Biol (2015) 0.78

Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities. Oncotarget (2016) 0.78

The role of machine learning in neuroimaging for drug discovery and development. Psychopharmacology (Berl) (2015) 0.78

Can animal data translate to innovations necessary for a new era of patient-centred and individualised healthcare? Bias in preclinical animal research. BMC Med Ethics (2015) 0.78

Evaluating Health Span in Preclinical Models of Aging and Disease: Guidelines, Challenges, and Opportunities for Geroscience. J Gerontol A Biol Sci Med Sci (2016) 0.78

A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray. Mol Oncol (2016) 0.78

Housing Temperature-Induced Stress Is Suppressing Murine Graft-versus-Host Disease through β2-Adrenergic Receptor Signaling. J Immunol (2015) 0.77

An orthotopic mouse model of small cell lung cancer reflects the clinical course in patients. Clin Exp Metastasis (2016) 0.77

Effect of Predatory Bacteria on Human Cell Lines. PLoS One (2016) 0.77

Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species. Invest New Drugs (2016) 0.76

Show and tell: disclosure and data sharing in experimental pathology. Dis Model Mech (2016) 0.76

Three-dimensional bio-printing: A new frontier in oncology research. World J Clin Oncol (2017) 0.75

A novel non-Hodgkin lymphoma murine model closer to the standard clinical scenario. J Transl Med (2016) 0.75

Animal Models of Uveal Melanoma: Methods, Applicability, and Limitations. Biomed Res Int (2016) 0.75

Human Organotypic Lung Tumor Models: Suitable For Preclinical 18F-FDG PET-Imaging. PLoS One (2016) 0.75

Engineered Swine Models of Cancer. Front Genet (2016) 0.75

Methylcholanthrene-Induced Sarcomas Develop Independently from NOX2-Derived ROS. PLoS One (2015) 0.75

Spheroid-plug model as a tool to study tumor development, angiogenesis, and heterogeneity in vivo. Tumour Biol (2015) 0.75

Developing a Collaborative Agenda for Humanities and Social Scientific Research on Laboratory Animal Science and Welfare. PLoS One (2016) 0.75

Modeling mania in preclinical settings: A comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry (2015) 0.75

Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer. Drug Des Devel Ther (2016) 0.75

A matter of timing: identifying significant multi-dose radiotherapy improvements by numerical simulation and genetic algorithm search. PLoS One (2014) 0.75

Good Science, Good Sense and Good Sensibilities: The Three Ss of Carol Newton. Animals (Basel) (2016) 0.75

Functional metabolic interactions of human neuron-astrocyte 3D in vitro networks. Sci Rep (2016) 0.75

Recommendations for Benchmarking Preclinical Studies of Nanomedicines. Cancer Res (2015) 0.75

Modeling Natural Killer Cell Targeted Immunotherapies. Front Immunol (2017) 0.75

Microenvironment complexity and matrix stiffness regulate breast cancer cell activity in a 3D in vitro model. Sci Rep (2016) 0.75

Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours. Sci Rep (2016) 0.75

Generalized paired-agent kinetic model for in vivo quantification of cancer cell-surface receptors under receptor saturation conditions. Phys Med Biol (2016) 0.75

Preclinical studies of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in pediatric brain tumors. J Neurooncol (2015) 0.75

Expression of miRNA-122 Induced by Liver Toxicants in Zebrafish. Biomed Res Int (2016) 0.75

Overview of the Use of Murine Models in Leukemia and Lymphoma Research. Front Oncol (2017) 0.75

Effect of cryopreservation on delineation of immune cell subpopulations in tumor specimens as determinated by multiparametric single cell mass cytometry analysis. BMC Immunol (2017) 0.75

CORR Insights(®): Are Biopsy Tracts a Concern for Seeding and Local Recurrence in Sarcomas? Clin Orthop Relat Res (2016) 0.75

Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis. Genome Med (2017) 0.75

Connectivity mapping (ssCMap) to predict A20-inducing drugs and their antiinflammatory action in cystic fibrosis. Proc Natl Acad Sci U S A (2016) 0.75

About ATMPs, SOPs and GMP: The Hurdles to Produce Novel Skin Grafts for Clinical Use. Transfus Med Hemother (2016) 0.75

From animal cage to aircraft cabin: an overview of evidence translation in jet lag research. Eur J Appl Physiol (2014) 0.75

Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap. Trends Cancer (2017) 0.75

Biomechanical regulation of drug sensitivity in an engineered model of human tumor. Biomaterials (2017) 0.75

Atlantic salmon cardiac primary cultures: An in vitro model to study viral host pathogen interactions and pathogenesis. PLoS One (2017) 0.75

Cancer Cell-Autonomous Parainflammation Mimics Immune Cell Infiltration. Cancer Res (2017) 0.75

Tumour and normal tissue radiobiology in mouse models: how close are mice to mini-humans? Br J Radiol (2016) 0.75

Models of Models: A Translational Route for Cancer Treatment and Drug Development. Front Oncol (2017) 0.75

Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration-Approved Drugs. Pharmacol Rev (2017) 0.75

Helminth Immunomodulation in Autoimmune Disease. Front Immunol (2017) 0.75

The Volume of Three-Dimensional Cultures of Cancer Cells InVitro Influences Transcriptional Profile Differences and Similarities with Monolayer Cultures and Xenografted Tumors. Neoplasia (2017) 0.75

Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs. Int J Genomics (2017) 0.75

Natural variation of macrophage activation as disease-relevant phenotype predictive of inflammation and cancer survival. Nat Commun (2017) 0.75

Progress and Future Prospectives in Skin-on-Chip Development with Emphasis on the use of Different Cell Types and Technical Challenges. Stem Cell Rev (2017) 0.75

A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition. J R Soc Interface (2017) 0.75

Articles cited by this

Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med (2006) 15.04

Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol (2010) 5.58

Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ (2006) 5.05

Translation of research evidence from animals to humans. JAMA (2006) 4.48

Trial watch: phase III and submission failures: 2007-2010. Nat Rev Drug Discov (2011) 2.73

Towards third generation matrix metalloproteinase inhibitors for cancer therapy. Br J Cancer (2006) 2.20

Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive. Neurosci Biobehav Rev (2002) 2.00

Medical progress depends on animal models - doesn't it? J R Soc Med (2008) 1.89

Matrix metalloproteinases as valid clinical targets. Curr Pharm Des (2007) 1.76

Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma. Nat Genet (2013) 1.45

Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility. Drugs (2010) 1.35

Translational research: 4 ways to fix the clinical trial. Nature (2011) 1.20

The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials. Br J Cancer (2007) 1.17

TGN1412: From Discovery to Disaster. J Young Pharm (2010) 1.16

Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model. Proc Natl Acad Sci U S A (2012) 1.13

Predictive in vivo animal models and translation to clinical trials. Drug Discov Today (2012) 1.12

Vaccination for treatment and prevention of cancer in animal models. Adv Immunol (2006) 1.11

Trials, tribulations, and trends in tumor modeling in mice. Toxicol Pathol (2004) 1.05

Immunological monitoring of anticancer vaccines in clinical trials. Oncoimmunology (2013) 0.95

Immunotherapy at large: the road to personalized cancer vaccines. Nat Med (2013) 0.93

One in five cancer clinical trials is published: a terrible symptom--what's the diagnosis? Oncologist (2008) 0.92

Cancer vaccines: Looking to the future. Oncoimmunology (2013) 0.88